BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17590128)

  • 1. [Rhabdomyolysis probably caused by interaction between efalizumab and pravastatin].
    Cid Conde L; Silveria Cancela D
    Farm Hosp; 2007; 31(2):135-6. PubMed ID: 17590128
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatal rhabdomyolysis following the co-prescription of fusidic acid and pravastatin.
    Bachoumas K; Fiancette M; Lascarrou JB; Lacherade JC; Leclair F; Reignier J
    Med Mal Infect; 2015 Oct; 45(10):417-9. PubMed ID: 26472060
    [No Abstract]   [Full Text] [Related]  

  • 3. Localized rhabdomyolysis after exertion in a cardiac transplant recipient on statin therapy.
    Biggs MJ; Bonser RS; Cram R
    J Heart Lung Transplant; 2006 Mar; 25(3):356-7. PubMed ID: 16507432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative rhabdomyolysis in a patient receiving pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitor.
    Rosenberg AD; Neuwirth MG; Kagen LJ; Singh K; Fischer HD; Bernstein RL
    Anesth Analg; 1995 Nov; 81(5):1089-91. PubMed ID: 7486053
    [No Abstract]   [Full Text] [Related]  

  • 5. Asymptomatic statin-induced rhabdomyolysis after long-term therapy with the hydrophilic drug pravastatin.
    Schindler C; Thorns M; Matschke K; Tugtekin SM; Kirch W
    Clin Ther; 2007 Jan; 29(1):172-6. PubMed ID: 17379057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myotoxicity and rhabdomyolisis due to statins].
    Cohen LH
    Ned Tijdschr Geneeskd; 2002 Mar; 146(9):440-1; author reply 441. PubMed ID: 11901950
    [No Abstract]   [Full Text] [Related]  

  • 7. Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors.
    Rowan C; Brinker AD; Nourjah P; Chang J; Mosholder A; Barrett JS; Avigan M
    Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):301-9. PubMed ID: 19206087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rhabdomyolysis and acute renal failure secondary to statins].
    Borrego FJ; Liébana A; Borrego J; Pérez del Barrio P; Gil JM; García Cortés MJ; Sánchez Perales C; Serrano P; Pérez Bañasco V
    Nefrologia; 2001; 21(3):309-13. PubMed ID: 11471312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HMG Co-A reductase inhibitors ('statins') and myotoxic effects.
    S Afr Med J; 2002 Aug; 92(8):596-7. PubMed ID: 12244613
    [No Abstract]   [Full Text] [Related]  

  • 10. HMG-CoA reductase inhibitor treatment in renal insufficiency.
    Wanner C
    Nephrol Dial Transplant; 1996 Oct; 11(10):1951-2. PubMed ID: 8918704
    [No Abstract]   [Full Text] [Related]  

  • 11. [Statin therapy and muscle disorders].
    Abel T; Fehér J
    Orv Hetil; 2009 Feb; 150(6):261-3. PubMed ID: 19179258
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rhabdomyolysis caused by pravastatin and type 1 macrocreatine kinase].
    Decoulx E; Millaire A; de Groote P; Mahieux G; Ducloux G
    Ann Cardiol Angeiol (Paris); 1993 May; 42(5):267-9. PubMed ID: 8368799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis.
    McAdams M; Staffa J; Dal Pan G
    Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):229-39. PubMed ID: 18175291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and statin therapy: reconsidering the risks and benefits.
    Gotto AM
    Arch Intern Med; 2003 Mar; 163(6):657-9. PubMed ID: 12639194
    [No Abstract]   [Full Text] [Related]  

  • 15. Muscular adverse effects of statins.
    Prescrire Int; 2003 Feb; 12(63):21. PubMed ID: 12602397
    [No Abstract]   [Full Text] [Related]  

  • 16. Rhabdomyolysis and acute renal failure after changing statin-fibrate combinations.
    Oldemeyer JB; Lund RJ; Koch M; Meares AJ; Dunlay R
    Cardiology; 2000; 94(2):127-8. PubMed ID: 11173785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The statins: drug interactions of significance to the dental practitioner.
    Stevenson H; Longman LP; Randall C; Field EA
    Dent Update; 2006; 33(1):14-6, 18, 20. PubMed ID: 16512094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhabdomyolysis and HMG-CoA reductase inhibitors.
    Omar MA; Wilson JP; Cox TS
    Ann Pharmacother; 2001 Sep; 35(9):1096-107. PubMed ID: 11573861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhabdomyolysis and statin therapy: relevance to the elderly.
    Sica DA; Gehr TW
    Am J Geriatr Cardiol; 2002; 11(1):48-55. PubMed ID: 11773716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerivastatin-induced rhabdomyolysis.
    Rodríguez ML; Mora C; Navarro JF
    Ann Intern Med; 2000 Apr; 132(7):598. PubMed ID: 10744612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.